Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?

BACKGROUND: Standard treatment for metastatic gastrointestinal stromal tumors (GISTs) is systemic therapy with imatinib. Surgery is performed to remove metastatic lesions to induce long-term remission or even curation. In other patients, surgery is performed to remove (focal) progressive or symptoma...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tielen, Ronald, Verhoef, Cornelis, van Coevorden, Frits, Gelderblom, Hans, Sleijfer, Stefan, Hartgrink, Henk H, Bonenkamp, Johannes J, van der Graaf, Winette T, de Wilt, Johannes H W
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422188/
https://ncbi.nlm.nih.gov/pubmed/22703877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-111
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky